The executive summary concisely highlights that the ependymoma market, starting at USD 149.86 million in 2023, is expected to achieve a significant growth rate of 4.80% annually, reaching approximately USD 228.5 million by 2032. This growth is primarily fueled by increased global investment in neuro-oncological research, expanding knowledge of ependymal tumors, and technological advancements in treatment […]